Vimarsana
Biggest News Aggregation in the World

Multi Center Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multi Center Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multi Center Study Today - Breaking & Trending Today

Studies Highlight Impacts of Applying New Technologies in Everyday Care - Vimarsana News

Studies Highlight Impacts of Applying New Technologies in Everyday Care

/PRNewswire/ -- Researchers report striking progress in the application of cutting-edge tools and treatments to address longstanding challenges in blood...

AI Algorithm Effectively Differentiates Between pre-PMF/ET - Vimarsana News

AI Algorithm Effectively Differentiates Between pre-PMF/ET

A machine learning, artificial intelligence algorithm analyzing diagnostic bone marrow biopsy digital whole-slide images was able to effectively differentiate with 92.3% accuracy between prefibrotic primary myelofibrosis and essential thrombocythemia.

RSNA 2023 At-a-Glance: 109th Scientific Assembly and Annual Meeting Set to Deliver Blockbuster Program - Vimarsana News

RSNA 2023 At-a-Glance: 109th Scientific Assembly and Annual Meeting Set to Deliver Blockbuster Program

The Radiological Society of North America is already making news as it unveils its RSNA 2023 program, set to deliver trends in radiology science, a wide range of education sessions, industry leaders, and featuring latest advances in medical imaging Nov. 26-30 in Chicago.

Anti-Obesity Medications As Medicare Part D Drugs: Legal And Health Policy Rationales - Healthcare - Vimarsana News

Anti-Obesity Medications As Medicare Part D Drugs: Legal And Health Policy Rationales - Healthcare

Obesity is a complex, multifactorial disease that has serious health consequences, affects millions of Americans and drives hundreds of billions of dollars in annual health care spending.

Source: mondaq.com
Transcenta to Present Two Clinical Trial Progress at ASCO 2023 - Vimarsana News

Transcenta to Present Two Clinical Trial Progress at ASCO 2023

/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...